Form 4: Pacific Biosciences CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Susan G. Kim, CFO of Pacific Biosciences, sold 5,275 shares of common stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 4, 2024, Susan G. Kim, the Chief Financial Officer of Pacific Biosciences, sold 5,275 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price ranging from $4.72 to $5.22 per share.
- Following the transaction, Kim directly owns 712,260 shares of Pacific Biosciences common stock, which includes 2,085 shares purchased on March 1, 2024, under the company's 2010 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | 2,085 shares purchased under the Company's 2010 Employee Stock Purchase Plan |
| 03/04/2024 | Date of stock sale transaction |
| 03/06/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.